Future studies on establishing the function of CCT2 as an oncogene and elucidating its relationship with MYC could undercover a novel mechanism underlying cancer growth and dissemination and reveal uses for CCT inhibitors in the treatment of drug resistant cancers and in the prevention of cancer relapse and metastasis. This evidence concerns the gene MYC and cancer.